Antiviral Oral Liquid and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Antiviral Oral Liquid Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiviral Oral Liquid Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiviral Oral Liquid Overall Market Size
2.1 Global Antiviral Oral Liquid Market Size: 2022 VS 2030
2.2 Global Antiviral Oral Liquid Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antiviral Oral Liquid Players in Global Market
3.2 Top Global Antiviral Oral Liquid Companies Ranked by Revenue
3.3 Global Antiviral Oral Liquid Revenue by Companies
3.4 Top 3 and Top 5 Antiviral Oral Liquid Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antiviral Oral Liquid Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antiviral Oral Liquid Players in Global Market
3.6.1 List of Global Tier 1 Antiviral Oral Liquid Companies
3.6.2 List of Global Tier 2 and Tier 3 Antiviral Oral Liquid Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antiviral Oral Liquid Market Size Markets, 2022 & 2030
4.1.2 Syrup
4.1.3 Oral suspension
4.1.4 Oral solution
4.1.5 Oral drop
4.1.6 Oral emulsion
4.1.7 Mixture
4.2 By Type - Global Antiviral Oral Liquid Revenue & Forecasts
4.2.1 By Type - Global Antiviral Oral Liquid Revenue, 2018-2023
4.2.2 By Type - Global Antiviral Oral Liquid Revenue, 2024-2030
4.2.3 By Type - Global Antiviral Oral Liquid Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antiviral Oral Liquid Market Size, 2022 & 2030
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Antiviral Oral Liquid Revenue & Forecasts
5.2.1 By Application - Global Antiviral Oral Liquid Revenue, 2018-2023
5.2.2 By Application - Global Antiviral Oral Liquid Revenue, 2024-2030
5.2.3 By Application - Global Antiviral Oral Liquid Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Antiviral Oral Liquid Market Size, 2022 & 2030
6.2 By Region - Global Antiviral Oral Liquid Revenue & Forecasts
6.2.1 By Region - Global Antiviral Oral Liquid Revenue, 2018-2023
6.2.2 By Region - Global Antiviral Oral Liquid Revenue, 2024-2030
6.2.3 By Region - Global Antiviral Oral Liquid Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Antiviral Oral Liquid Revenue, 2018-2030
6.3.2 US Antiviral Oral Liquid Market Size, 2018-2030
6.3.3 Canada Antiviral Oral Liquid Market Size, 2018-2030
6.3.4 Mexico Antiviral Oral Liquid Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Antiviral Oral Liquid Revenue, 2018-2030
6.4.2 Germany Antiviral Oral Liquid Market Size, 2018-2030
6.4.3 France Antiviral Oral Liquid Market Size, 2018-2030
6.4.4 U.K. Antiviral Oral Liquid Market Size, 2018-2030
6.4.5 Italy Antiviral Oral Liquid Market Size, 2018-2030
6.4.6 Russia Antiviral Oral Liquid Market Size, 2018-2030
6.4.7 Nordic Countries Antiviral Oral Liquid Market Size, 2018-2030
6.4.8 Benelux Antiviral Oral Liquid Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Antiviral Oral Liquid Revenue, 2018-2030
6.5.2 China Antiviral Oral Liquid Market Size, 2018-2030
6.5.3 Japan Antiviral Oral Liquid Market Size, 2018-2030
6.5.4 South Korea Antiviral Oral Liquid Market Size, 2018-2030
6.5.5 Southeast Asia Antiviral Oral Liquid Market Size, 2018-2030
6.5.6 India Antiviral Oral Liquid Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Antiviral Oral Liquid Revenue, 2018-2030
6.6.2 Brazil Antiviral Oral Liquid Market Size, 2018-2030
6.6.3 Argentina Antiviral Oral Liquid Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antiviral Oral Liquid Revenue, 2018-2030
6.7.2 Turkey Antiviral Oral Liquid Market Size, 2018-2030
6.7.3 Israel Antiviral Oral Liquid Market Size, 2018-2030
6.7.4 Saudi Arabia Antiviral Oral Liquid Market Size, 2018-2030
6.7.5 UAE Antiviral Oral Liquid Market Size, 2018-2030
7 Antiviral Oral Liquid Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antiviral Oral Liquid Major Product Offerings
7.1.4 Pfizer Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Antiviral Oral Liquid Major Product Offerings
7.2.4 Roche Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Antiviral Oral Liquid Major Product Offerings
7.3.4 Novartis Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Antiviral Oral Liquid Major Product Offerings
7.4.4 Merck Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Antiviral Oral Liquid Major Product Offerings
7.5.4 GlaxoSmithKline Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Antiviral Oral Liquid Major Product Offerings
7.6.4 Johnson & Johnson Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Antiviral Oral Liquid Major Product Offerings
7.7.4 AbbVie Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Antiviral Oral Liquid Major Product Offerings
7.8.4 Sanofi Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Major Product Offerings
7.9.4 Bristol-Myers Squibb Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Antiviral Oral Liquid Major Product Offerings
7.10.4 AstraZeneca Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.10.5 AstraZeneca Key News & Latest Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Company Summary
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Antiviral Oral Liquid Major Product Offerings
7.11.4 Eli Lilly Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.11.5 Eli Lilly Key News & Latest Developments
7.12 Novo Nordisk
7.12.1 Novo Nordisk Company Summary
7.12.2 Novo Nordisk Business Overview
7.12.3 Novo Nordisk Antiviral Oral Liquid Major Product Offerings
7.12.4 Novo Nordisk Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.12.5 Novo Nordisk Key News & Latest Developments
7.13 Amgen
7.13.1 Amgen Company Summary
7.13.2 Amgen Business Overview
7.13.3 Amgen Antiviral Oral Liquid Major Product Offerings
7.13.4 Amgen Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.13.5 Amgen Key News & Latest Developments
7.14 Gilead Sciences
7.14.1 Gilead Sciences Company Summary
7.14.2 Gilead Sciences Business Overview
7.14.3 Gilead Sciences Antiviral Oral Liquid Major Product Offerings
7.14.4 Gilead Sciences Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.14.5 Gilead Sciences Key News & Latest Developments
7.15 CSL
7.15.1 CSL Company Summary
7.15.2 CSL Business Overview
7.15.3 CSL Antiviral Oral Liquid Major Product Offerings
7.15.4 CSL Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.15.5 CSL Key News & Latest Developments
7.16 Takeda Pharmaceuticals
7.16.1 Takeda Pharmaceuticals Company Summary
7.16.2 Takeda Pharmaceuticals Business Overview
7.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Major Product Offerings
7.16.4 Takeda Pharmaceuticals Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.16.5 Takeda Pharmaceuticals Key News & Latest Developments
7.17 Bayer
7.17.1 Bayer Company Summary
7.17.2 Bayer Business Overview
7.17.3 Bayer Antiviral Oral Liquid Major Product Offerings
7.17.4 Bayer Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.17.5 Bayer Key News & Latest Developments
7.18 Celgene
7.18.1 Celgene Company Summary
7.18.2 Celgene Business Overview
7.18.3 Celgene Antiviral Oral Liquid Major Product Offerings
7.18.4 Celgene Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.18.5 Celgene Key News & Latest Developments
7.19 Merck KGaA
7.19.1 Merck KGaA Company Summary
7.19.2 Merck KGaA Business Overview
7.19.3 Merck KGaA Antiviral Oral Liquid Major Product Offerings
7.19.4 Merck KGaA Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.19.5 Merck KGaA Key News & Latest Developments
7.20 Allergan
7.20.1 Allergan Company Summary
7.20.2 Allergan Business Overview
7.20.3 Allergan Antiviral Oral Liquid Major Product Offerings
7.20.4 Allergan Antiviral Oral Liquid Revenue in Global Market (2018-2023)
7.20.5 Allergan Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Antiviral Oral Liquid Market Opportunities & Trends in Global Market
Table 2. Antiviral Oral Liquid Market Drivers in Global Market
Table 3. Antiviral Oral Liquid Market Restraints in Global Market
Table 4. Key Players of Antiviral Oral Liquid in Global Market
Table 5. Top Antiviral Oral Liquid Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antiviral Oral Liquid Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antiviral Oral Liquid Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antiviral Oral Liquid Product Type
Table 9. List of Global Tier 1 Antiviral Oral Liquid Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiviral Oral Liquid Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Antiviral Oral Liquid Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Antiviral Oral Liquid Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antiviral Oral Liquid Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Antiviral Oral Liquid Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Antiviral Oral Liquid Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antiviral Oral Liquid Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Antiviral Oral Liquid Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Antiviral Oral Liquid Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antiviral Oral Liquid Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antiviral Oral Liquid Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antiviral Oral Liquid Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antiviral Oral Liquid Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antiviral Oral Liquid Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antiviral Oral Liquid Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Antiviral Oral Liquid Product Offerings
Table 32. Pfizer Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Antiviral Oral Liquid Product Offerings
Table 36. Roche Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Antiviral Oral Liquid Product Offerings
Table 40. Novartis Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Antiviral Oral Liquid Product Offerings
Table 44. Merck Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Antiviral Oral Liquid Product Offerings
Table 48. GlaxoSmithKline Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Antiviral Oral Liquid Product Offerings
Table 52. Johnson & Johnson Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Antiviral Oral Liquid Product Offerings
Table 56. AbbVie Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Antiviral Oral Liquid Product Offerings
Table 60. Sanofi Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Antiviral Oral Liquid Product Offerings
Table 64. Bristol-Myers Squibb Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Antiviral Oral Liquid Product Offerings
Table 68. AstraZeneca Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 69. AstraZeneca Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Antiviral Oral Liquid Product Offerings
Table 72. Eli Lilly Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. Novo Nordisk Company Summary
Table 75. Novo Nordisk Antiviral Oral Liquid Product Offerings
Table 76. Novo Nordisk Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 77. Novo Nordisk Key News & Latest Developments
Table 78. Amgen Company Summary
Table 79. Amgen Antiviral Oral Liquid Product Offerings
Table 80. Amgen Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 81. Amgen Key News & Latest Developments
Table 82. Gilead Sciences Company Summary
Table 83. Gilead Sciences Antiviral Oral Liquid Product Offerings
Table 84. Gilead Sciences Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 85. Gilead Sciences Key News & Latest Developments
Table 86. CSL Company Summary
Table 87. CSL Antiviral Oral Liquid Product Offerings
Table 88. CSL Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 89. CSL Key News & Latest Developments
Table 90. Takeda Pharmaceuticals Company Summary
Table 91. Takeda Pharmaceuticals Antiviral Oral Liquid Product Offerings
Table 92. Takeda Pharmaceuticals Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 93. Takeda Pharmaceuticals Key News & Latest Developments
Table 94. Bayer Company Summary
Table 95. Bayer Antiviral Oral Liquid Product Offerings
Table 96. Bayer Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 97. Bayer Key News & Latest Developments
Table 98. Celgene Company Summary
Table 99. Celgene Antiviral Oral Liquid Product Offerings
Table 100. Celgene Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 101. Celgene Key News & Latest Developments
Table 102. Merck KGaA Company Summary
Table 103. Merck KGaA Antiviral Oral Liquid Product Offerings
Table 104. Merck KGaA Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 105. Merck KGaA Key News & Latest Developments
Table 106. Allergan Company Summary
Table 107. Allergan Antiviral Oral Liquid Product Offerings
Table 108. Allergan Antiviral Oral Liquid Revenue (US$, Mn) & (2018-2023)
Table 109. Allergan Key News & Latest Developments
List of Figures
Figure 1. Antiviral Oral Liquid Segment by Type in 2022
Figure 2. Antiviral Oral Liquid Segment by Application in 2022
Figure 3. Global Antiviral Oral Liquid Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antiviral Oral Liquid Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Antiviral Oral Liquid Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antiviral Oral Liquid Revenue in 2022
Figure 8. By Type - Global Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 9. By Application - Global Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 10. By Type - Global Antiviral Oral Liquid Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 12. By Application - Global Antiviral Oral Liquid Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 14. By Region - Global Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 15. By Country - North America Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 16. US Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 20. Germany Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 21. France Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 28. China Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 32. India Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 34. Brazil Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Antiviral Oral Liquid Revenue Market Share, 2018-2030
Figure 37. Turkey Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Antiviral Oral Liquid Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AbbVie Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AstraZeneca Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Eli Lilly Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Novo Nordisk Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Amgen Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Gilead Sciences Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. CSL Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Takeda Pharmaceuticals Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Bayer Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Celgene Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Merck KGaA Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Allergan Antiviral Oral Liquid Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
